Virginia Tech®home

Research Development Series: Strategies for Winning National Institutes of Health Program Project/Center Grants

How can researchers elevate health-related research to the next level?

The National Institutes of Health (NIH) provide the largest amount of public funding for biomedical research in the world. The most substantial awards are program project/center grants (P-series) that support large, multi-project efforts that generally include a diverse array of research activities. 

As part of its Research Development Series, the Office of Research and Innovation is hosting a seminar designed to inspire both experienced and new research faculty, by providing an overview of P-series grants and the winning strategies used by invited speakers.   

Research Development Series: Strategies for Winning National Institutes of Health Program Project/Center Grants

Sept. 9, 2022 | 1:30 - 2:30 p.m.
Virtual

Host

Vince Baranauskas  portrait.

Vince Baranauskas

Senior Research Development Coordinator

Speakers

Sheree Toth

Director, Mt. Hope Family Center
Professor of Psychology and Psychiatry
University of Rochester

Sheree Toth, director of the Mt. Hope Family Center in Rochester, New York, was awarded a P-50 Capstone Grant to establish the center as one of three national centers on child abuse and neglect. Under Toth’s leadership, the center has conducted rigorous and innovative empirical research with maltreated children and their families for nearly 40 years. The center also leads numerous trainings locally and nationally on the implementation of evidence-based treatments by translating research into practice.

Mark Peeples

Professor, Department of Pediatrics
Ohio State University College of Medicine
Center for Vaccines and Immunity
Abigail Wexner Research Institute at Nationwide Children's Hospital

Mark Peeples is a principal investigator for the Center for Vaccines and Immunity at the Abigail Wexner Research Institute at Nationwide Children’s Hospital. His team and collaborators have spent the past seven years developing novel RSV vaccines and testing them in cotton rats, supported by an NIH P01. A year ago, the team published a preclinical trial of their first RSV live attenuated vaccine candidate trial and also submitted their P01 renewal application to complete that work.

About this series 

In January 2021, the Office of Research and Innovation launched its Research Development Series to help faculty in their journey to increase the scope and impact of their research, creativity, and innovation portfolio. With events focused on different facets of sponsored research, from sponsor-specific perspectives to how to work with partners, this webinar series is intended to answer researchers' biggest questions and enlighten scholars at every step in their career.